{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:38:02Z","timestamp":1780576682985,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s00415-011-5980-6","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T21:47:56Z","timestamp":1301089676000},"page":"1624-1631","source":"Crossref","is-referenced-by-count":46,"title":["Can vitamin D3 supplementation prevent bone loss in persons with MS? A placebo-controlled trial"],"prefix":"10.1007","volume":"258","author":[{"given":"Linn H.","family":"Steffensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Straume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein Ivar","family":"Mellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margitta T.","family":"Kampman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,13]]},"reference":[{"key":"5980_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1474-4422(10)70086-7","volume":"9","author":"A Ascherio","year":"2010","unstructured":"Ascherio A, Munger KL, Simon KC (2010) Vitamin D and multiple sclerosis. Lancet Neurol 9:599\u2013612","journal-title":"Lancet Neurol"},{"key":"5980_CR2","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/jbmr.95","volume":"25","author":"C Berger","year":"2010","unstructured":"Berger C, Goltzman D, Langsetmo L, Joseph L, Jackson S, Kreiger N, Tenenhouse A, Davison KS, Josse RG, Prior JC, Hanley DA (2010) Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res 25:1948\u20131957","journal-title":"J Bone Miner Res"},{"key":"5980_CR3","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1503\/cmaj.071416","volume":"178","author":"C Berger","year":"2008","unstructured":"Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse R, Kreiger N, Tenenhouse A, Goltzman D (2008) Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 178:1660\u20131668","journal-title":"CMAJ"},{"key":"5980_CR4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00198-006-0293-9","volume":"18","author":"HA Bischoff-Ferrari","year":"2007","unstructured":"Bischoff-Ferrari HA (2007) How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 18:401\u2013407","journal-title":"Osteoporos Int"},{"key":"5980_CR5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.amjmed.2003.12.029","volume":"116","author":"HA Bischoff-Ferrari","year":"2004","unstructured":"Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116:634\u2013639","journal-title":"Am J Med"},{"key":"5980_CR6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archinternmed.2008.600","volume":"169","author":"HA Bischoff-Ferrari","year":"2009","unstructured":"Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, Thoma A, Kiel DP, Henschkowski J (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169:551\u2013561","journal-title":"Arch Intern Med"},{"key":"5980_CR7","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","volume":"74","author":"JM Burton","year":"2010","unstructured":"Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D\u2019Souza C, Ursell M, O\u2019Connor P (2010) A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 74:1852\u20131859","journal-title":"Neurology"},{"key":"5980_CR8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s001980070091","volume":"11","author":"RD Chapurlat","year":"2000","unstructured":"Chapurlat RD, Garnero P, Sornay-Rendu E, Arlot ME, Claustrat B, Delmas PD (2000) Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int 11:493\u2013498","journal-title":"Osteoporos Int"},{"key":"5980_CR9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00198-007-0465-2","volume":"19","author":"V Chel","year":"2008","unstructured":"Chel V, Wijnhoven HA, Smit JH, Ooms M, Lips P (2008) Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 19:663\u2013671","journal-title":"Osteoporos Int"},{"key":"5980_CR10","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.51.4.1161","volume":"51","author":"F Cosman","year":"1998","unstructured":"Cosman F, Nieves J, Komar L, Ferrer G, Herbert J, Formica C, Shen V, Lindsay R (1998) Fracture history and bone loss in patients with MS. Neurology 51:1161\u20131165","journal-title":"Neurology"},{"key":"5980_CR11","doi-asserted-by":"crossref","first-page":"513S","DOI":"10.1093\/ajcn\/88.2.513S","volume":"88","author":"A Cranney","year":"2008","unstructured":"Cranney A, Weiler HA, O\u2019Donnell S, Puil L (2008) Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 88:513S\u2013519S","journal-title":"Am J Clin Nutr"},{"key":"5980_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00198-005-1867-7","volume":"16","author":"B Dawson-Hughes","year":"2005","unstructured":"Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713\u2013716","journal-title":"Osteoporos Int"},{"key":"5980_CR13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/aje\/kwi258","volume":"162","author":"N Emaus","year":"2005","unstructured":"Emaus N, Berntsen GK, Joakimsen RM, Fonnebo V (2005) Longitudinal changes in forearm bone mineral density in women and men aged 25\u201344\u00a0years: the Tromso study: a population-based study. Am J Epidemiol 162:633\u2013643","journal-title":"Am J Epidemiol"},{"key":"5980_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10654-009-9333-z","volume":"24","author":"N Emaus","year":"2009","unstructured":"Emaus N, Omsland TK, Ahmed LA, Grimnes G, Sneve M, Berntsen GK (2009) Bone mineral density at the hip in Norwegian women and men-prevalence of osteoporosis depends on chosen references: the Tromso Study. Eur J Epidemiol 24:321\u2013328","journal-title":"Eur J Epidemiol"},{"key":"5980_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-10-0150","volume":"163","author":"G Grimnes","year":"2010","unstructured":"Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, Hopstock LA, Hutchinson MS, Methlie P, Mihailova A, Sneve M, Torjesen P, Wilsgaard T, Jorde R (2010) Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 163:339\u2013348","journal-title":"Eur J Endocrinol"},{"key":"5980_CR16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/13697130701258838","volume":"10","author":"SD Harlow","year":"2007","unstructured":"Harlow SD, Crawford S, Dennerstein L, Burger HG, Mitchell ES, Sowers MF (2007) Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging. Climacteric 10:112\u2013119","journal-title":"Climacteric"},{"key":"5980_CR17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/1352458510368985","volume":"16","author":"AP Hearn","year":"2010","unstructured":"Hearn AP, Silber E (2010) Osteoporosis in multiple sclerosis. Mult Scler 16:1031\u20131043","journal-title":"Mult Scler"},{"key":"5980_CR18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00198-009-1042-7","volume":"21","author":"MJ Henry","year":"2010","unstructured":"Henry MJ, Pasco JA, Korn S, Gibson JE, Kotowicz MA, Nicholson GC (2010) Bone mineral density reference ranges for Australian men: Geelong Osteoporosis Study. Osteoporos Int 21:909\u2013917","journal-title":"Osteoporos Int"},{"key":"5980_CR19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266\u2013281","journal-title":"N Engl J Med"},{"key":"5980_CR20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jphotobiol.2010.04.003","volume":"101","author":"MT Kampman","year":"2010","unstructured":"Kampman MT, Steffensen LH (2010) The role of vitamin D in multiple sclerosis. J Photochem Photobiol B 101:137\u2013141","journal-title":"J Photochem Photobiol B"},{"key":"5980_CR21","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"key":"5980_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S0029665108007003","volume":"67","author":"SA Lanham-New","year":"2008","unstructured":"Lanham-New SA (2008) Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment. Proc Nutr Soc 67:163\u2013176","journal-title":"Proc Nutr Soc"},{"key":"5980_CR23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den NS, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121\u2013127","journal-title":"Ann Neurol"},{"key":"5980_CR24","unstructured":"National osteoporosis foundation. Clinician\u2019s guide to prevention and treatment of osteoporosis. Available at: http:\/\/www.osteoporosisnews.org\/professionals\/pdfs\/NOF_ClinicianGuide2009_v7.pdf . Revised January 2010. Accessed February 01, 2011"},{"key":"5980_CR25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1749-6632.2009.05233.x","volume":"1192","author":"RM Neer","year":"2010","unstructured":"Neer RM (2010) Bone loss across the menopausal transition. Ann N Y Acad Sci 1192:66\u201371","journal-title":"Ann N Y Acad Sci"},{"key":"5980_CR26","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","volume":"44","author":"J Nieves","year":"1994","unstructured":"Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687\u20131692","journal-title":"Neurology"},{"key":"5980_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00774-005-0604-9","volume":"23","author":"S Ozgocmen","year":"2005","unstructured":"Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y (2005) Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab 23:309\u2013313","journal-title":"J Bone Miner Metab"},{"key":"5980_CR28","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/brain\/awq147","volume":"133","author":"C Pierrot-Deseilligny","year":"2010","unstructured":"Pierrot-Deseilligny C, Souberbielle JC (2010) Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain 133:1869\u20131888","journal-title":"Brain"},{"key":"5980_CR29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/bmj.39050.597350.47","volume":"333","author":"KE Poole","year":"2006","unstructured":"Poole KE, Compston JE (2006) Osteoporosis and its management. BMJ 333:1251\u20131256","journal-title":"BMJ"},{"key":"5980_CR30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00415-008-0543-1","volume":"255","author":"M Pugliatti","year":"2008","unstructured":"Pugliatti M, Riise T, Nortvedt MW, Carpentras G, Sotgiu MA, Sotgiu S, Rosati G (2008) Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients. J Neurol 255:157\u2013162","journal-title":"J Neurol"},{"key":"5980_CR31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1474-4422(10)70132-0","volume":"9","author":"M Ravnborg","year":"2010","unstructured":"Ravnborg M, Sorensen PS, Andersson M, Celius EG, Jongen PJ, Elovaara I, Bartholome E, Constantinescu CS, Beer K, Garde E, Sperling B (2010) Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial. Lancet Neurol 9:672\u2013680","journal-title":"Lancet Neurol"},{"key":"5980_CR32","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1359\/jbmr.2000.15.10.1965","volume":"15","author":"R Recker","year":"2000","unstructured":"Recker R, Lappe J, Davies K, Heaney R (2000) Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 15:1965\u20131973","journal-title":"J Bone Miner Res"},{"key":"5980_CR33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1530\/EJE-08-0339","volume":"159","author":"M Sneve","year":"2008","unstructured":"Sneve M, Figenschau Y, Jorde R (2008) Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 159:675\u2013684","journal-title":"Eur J Endocrinol"},{"key":"5980_CR34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(09)70085-7","volume":"8","author":"PS Sorensen","year":"2009","unstructured":"Sorensen PS, Mellgren SI, Svenningsson A, Elovaara I, Frederiksen JL, Beiske AG, Myhr KM, Sogaard LV, Olsen IC, Sandberg-Wollheim M (2009) NORdic trial of oral Methylprednisolone as add-on therapy to interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. Lancet Neurol 8:519\u2013529","journal-title":"Lancet Neurol"},{"key":"5980_CR35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00415-009-5337-6","volume":"257","author":"LH Steffensen","year":"2010","unstructured":"Steffensen LH, Mellgren SI, Kampman MT (2010) Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis. J Neurol 257:410\u2013418","journal-title":"J Neurol"},{"key":"5980_CR36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","volume":"370","author":"BM Tang","year":"2007","unstructured":"Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50\u00a0years and older: a meta-analysis. Lancet 370:657\u2013666","journal-title":"Lancet"},{"key":"5980_CR37","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jocn.2010.01.044","volume":"17","author":"T Terzi","year":"2010","unstructured":"Terzi T, Terzi M, Tander B, Canturk F, Onar M (2010) Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables. J Clin Neurosci 17:1260\u20131264","journal-title":"J Clin Neurosci"},{"key":"5980_CR38","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1191\/1352458503ms966oa","volume":"9","author":"S Tuzun","year":"2003","unstructured":"Tuzun S, Altintas A, Karacan I, Tangurek S, Saip S, Siva A (2003) Bone status in multiple sclerosis: beyond corticosteroids. Mult Scler 9:600\u2013604","journal-title":"Mult Scler"},{"key":"5980_CR39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/1352458504ms993oa","volume":"10","author":"B Weinstock-Guttman","year":"2004","unstructured":"Weinstock-Guttman B, Gallagher E, Baier M, Green L, Feichter J, Patrick K, Miller C, Wrest K, Ramanathan M (2004) Risk of bone loss in men with multiple sclerosis. Mult Scler 10:170\u2013175","journal-title":"Mult Scler"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00415-011-5980-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T12:53:53Z","timestamp":1560084833000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-5980-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,13]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["5980"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-5980-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,13]]}}}